Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Mastectomy | ASO Author Reflections

ASO Author Reflections: Contralateral Prophylactic Mastectomy—Moving Beyond Sociodemographic Factors

Authors: Tawakalitu O. Oseni, MD, Biqi Zhang, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

The adoption of widespread mammography screening has resulted in a significant increase in the incidence of ductal carcinoma in situ (DCIS).1 Lack of clinicopathologic criteria to effectively risk stratify DCIS lesions has led to significant controversy regarding clinical management and possibly overtreatment. Studies have demonstrated a significant increase in the use of contralateral prophylactic mastectomy (CPM) in the management of DCIS, without any improvement in overall survival.2 In assessing the predictors of CPM use, many studies have focused on sociodemographic factors. These studies consistently show that younger, Caucasian women of higher socioeconomic strata are more likely to undergo CPM. Assessment of the clinical, pathologic, and patient factors that influence the selection of CPM is important in guiding clinical decision making. Less attention has been given to other factors, which may impact treatment choice. More importantly, there is a paucity of data in the literature regarding treatment trends in non-Caucasian women. …
Literature
1.
go back to reference Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.CrossRef Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.CrossRef
2.
go back to reference Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7.CrossRef Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7.CrossRef
3.
go back to reference Zhang B, Coopey SB, Gadd MA, et al. Trends in unilateral and contralateral prophylactic mastectomy use in ductal carcinoma in situ of the breast: patterns and predictors. Ann Surg Oncol. 2019;26:3863–73.CrossRef Zhang B, Coopey SB, Gadd MA, et al. Trends in unilateral and contralateral prophylactic mastectomy use in ductal carcinoma in situ of the breast: patterns and predictors. Ann Surg Oncol. 2019;26:3863–73.CrossRef
4.
go back to reference Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES (2015) Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst. 107(12), djv263.CrossRef Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES (2015) Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst. 107(12), djv263.CrossRef
5.
go back to reference Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study. Eur J Cancer. 2015;51:1497–510.CrossRef Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study. Eur J Cancer. 2015;51:1497–510.CrossRef
6.
go back to reference Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303.CrossRef Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303.CrossRef
Metadata
Title
ASO Author Reflections: Contralateral Prophylactic Mastectomy—Moving Beyond Sociodemographic Factors
Authors
Tawakalitu O. Oseni, MD
Biqi Zhang, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Keyword
Mastectomy
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07998-1

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue